Studies reported high PAPP-A levels in asthma, COPD, lung cancer, and chronic renal diseases where oxidative stress and inflammation play a role in pathogenesis [15, 17, 29]. This evidence concerns the gene PAPPA and chronic obstructive pulmonary disease.